Dencare (Chongqing) Oral Care Co., Ltd. (SHE:001328)
China · Delayed Price · Currency is CNY 32.31
-0.71 (-2.15%)
Oct 28, 2026, 4:00 PM EDT
SHE:001328 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Operating Revenue | 1,911 | 1,714 | 1,558 | 1,374 | 1,311 | 1,140 |
Other Revenue | 1.59 | 1.59 | 2.27 | 2.22 | 2.26 | 2.41 |
| 1,913 | 1,716 | 1,560 | 1,376 | 1,313 | 1,143 | |
Revenue Growth | 10.23% | 9.98% | 13.40% | 4.75% | 14.95% | 10.97% |
Cost of Revenue | 890.31 | 822.6 | 795.74 | 771.84 | 785.81 | 665.92 |
Gross Profit | 1,023 | 893.23 | 764.33 | 603.94 | 527.52 | 476.6 |
Selling, General & Admin | 746.62 | 666.17 | 572.35 | 453.19 | 369.6 | 327.75 |
Research & Development | 56.37 | 52.25 | 48.07 | 42.73 | 40.13 | 35.52 |
Other Operating Expenses | 15.81 | 6.97 | 3.35 | 3.69 | 8.8 | -5.34 |
Operating Expenses | 819.96 | 725.63 | 623.25 | 499.22 | 419.21 | 358.18 |
Operating Income | 202.7 | 167.6 | 141.08 | 104.72 | 108.3 | 118.42 |
Interest Expense | -0.81 | -0.81 | -1.2 | -1.42 | -1.86 | -1.99 |
Interest & Investment Income | 32.27 | 31.39 | 27.57 | 20.01 | 14.76 | 20.4 |
Other Non Operating Income (Expenses) | -3.01 | -0.06 | 0.16 | -0.51 | -0.22 | 0.17 |
EBT Excluding Unusual Items | 231.14 | 198.12 | 167.61 | 122.8 | 120.98 | 137 |
Gain (Loss) on Sale of Investments | -3.71 | -1.53 | 6.65 | 11.1 | 0.1 | 0.64 |
Gain (Loss) on Sale of Assets | -0.11 | -0.01 | -0.15 | - | 0.61 | - |
Asset Writedown | 0.52 | - | - | -0.19 | - | -2.9 |
Other Unusual Items | 11.95 | 11.86 | 12.76 | 27.11 | 24.05 | - |
Pretax Income | 239.79 | 208.45 | 186.87 | 160.82 | 145.76 | 134.73 |
Income Tax Expense | 33.82 | 27.37 | 25.69 | 19.52 | 11.14 | 15.87 |
Net Income | 205.97 | 181.08 | 161.18 | 141.3 | 134.61 | 118.86 |
Net Income to Common | 205.97 | 181.08 | 161.18 | 141.3 | 134.61 | 118.86 |
Net Income Growth | 14.99% | 12.35% | 14.07% | 4.97% | 13.25% | 24.80% |
Shares Outstanding (Basic) | 172 | 172 | 171 | 161 | 129 | 129 |
Shares Outstanding (Diluted) | 172 | 172 | 171 | 161 | 129 | 129 |
Shares Change | 0.57% | 0.58% | 6.79% | 24.05% | 0.18% | 7.17% |
EPS (Basic) | 1.19 | 1.05 | 0.94 | 0.88 | 1.04 | 0.92 |
EPS (Diluted) | 1.19 | 1.05 | 0.94 | 0.88 | 1.04 | 0.92 |
EPS Growth | 14.33% | 11.70% | 6.82% | -15.38% | 13.04% | 16.46% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 137.81 | 165.52 | 134.34 | 106.67 | 27.98 | 49.28 |
Free Cash Flow Per Share | 0.80 | 0.96 | 0.78 | 0.66 | 0.22 | 0.38 |
Dividend Per Share | 0.850 | 0.850 | 0.750 | 0.650 | 0.600 | 0.780 |
Dividend Growth | 13.33% | 13.33% | 15.38% | 8.33% | -23.08% | - |
Gross Margin | 53.46% | 52.06% | 48.99% | 43.90% | 40.17% | 41.72% |
Operating Margin | 10.60% | 9.77% | 9.04% | 7.61% | 8.25% | 10.37% |
Profit Margin | 10.77% | 10.55% | 10.33% | 10.27% | 10.25% | 10.40% |
Free Cash Flow Margin | 7.20% | 9.65% | 8.61% | 7.75% | 2.13% | 4.31% |
EBITDA | 222.45 | 187.91 | 162.13 | 117.25 | 118.54 | 129.25 |
EBITDA Margin | 11.63% | 10.95% | 10.39% | 8.52% | 9.03% | 11.31% |
D&A For EBITDA | 19.76 | 20.31 | 21.05 | 12.53 | 10.23 | 10.83 |
EBIT | 202.7 | 167.6 | 141.08 | 104.72 | 108.3 | 118.42 |
EBIT Margin | 10.60% | 9.77% | 9.04% | 7.61% | 8.25% | 10.37% |
Effective Tax Rate | 14.11% | 13.13% | 13.75% | 12.14% | 7.65% | 11.78% |
Revenue as Reported | 1,913 | 1,716 | 1,560 | 1,376 | 1,313 | 1,143 |
Advertising Expenses | - | 420.37 | 359.73 | 254.27 | 189.09 | 161.94 |